Viewing Study NCT04400695


Ignite Creation Date: 2025-12-24 @ 1:40 PM
Ignite Modification Date: 2025-12-30 @ 4:27 PM
Study NCT ID: NCT04400695
Status: RECRUITING
Last Update Posted: 2024-01-24
First Post: 2020-04-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2
Sponsor: RemeGen Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module